Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 1;5(4):e227964.
doi: 10.1001/jamanetworkopen.2022.7964.

Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US

Marian Jarlenski  1   2 , Qingwen Chen  1 , Alice Gao  1 , Scott D Rothenberger  3 , Elizabeth E Krans  2   4   5
Affiliations

Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US

Marian Jarlenski et al. JAMA Netw Open. .

Abstract

This cohort study evaluates the association of the duration of methadone or buprenorphine use during pregnancy and the risk of nonfatal drug overdose among pregnant persons with opioid use disorder in the US.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Krans reported receiving grants from Gilead, Merck, and the National Institutes of Health outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Association of the Duration of Medication for Opioid Use Disorder (MOUD) During Pregnancy and the Risk of Nonfatal Overdose Among Commercially Insured Pregnant Persons in the US
Adjusted relative risks are from generalized estimating equations using a Poisson model with robust SEs. Multivariable models were controlled for patient age, race and ethnicity, number of medical comorbidities, and presence of any co-occurring nonopioid substance use disorders.
See this image and copyright information in PMC

References

    1. Jarlenski M, Krans EE, Chen Q, et al. . Substance use disorders and risk of severe maternal morbidity in the United States. Drug Alcohol Depend. 2020;216:108236. doi:10.1016/j.drugalcdep.2020.108236 - DOI - PMC - PubMed
    1. Smid MC, Schauberger CW, Terplan M, Wright TE. Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction. Am J Obstet Gynecol MFM. 2020;2(4):100177. doi:10.1016/j.ajogmf.2020.100177 - DOI - PMC - PubMed
    1. Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017;26(5):509-517. doi:10.1002/pds.4157 - DOI - PubMed
    1. Gao YA, Drake C, Krans EE, Chen Q, Jarlenski MP. Explaining racial-ethnic disparities in the receipt of medication for opioid use disorder during pregnancy. J Addict Med. 2022. doi:10.1097/ADM.0000000000000979 - DOI - PMC - PubMed
    1. Schiff DM, Nielsen T, Hoeppner BB, et al. . Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3(5):e205734. doi:10.1001/jamanetworkopen.2020.5734 - DOI - PMC - PubMed

Publication types